Tennessee tops in nation for Rx drug use

Share this article:
Residents of Tennessee use more prescription drugs than any other state in the nation – an average of 17.3 prescriptions for every man, woman and child, according to a report published on the Web site of the newspaper The Tennessean. The state’s prescription drug spending topped $7 billion in 2005, the article said, citing figures from a report compiled by BlueCross BlueShield of Tennessee, Tennessee is well above the national average of 11.3 prescriptions per person, according to the BlueCross report. The most commonly prescribed drug in Tennesee is hydrocodone, a narcotic that accounts for 2.8% of all the prescriptions in the state, the BlueCross study found. Rounding out the top 10 prescriptions in Tennessee were: *Lipitor for high cholesterol. *Nexium for heartburn. *Alprazolam for anxiety. *Levothyrxine, for thyroid problems. *Lisinopril for blood pressure regulation. *Zyrtec allergy pills. *The diuretic hydrochlorothiazide. *Azithromycin, an antibiotic. *Metformin HCL, a treatment for diabetes.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...